MultiPlan (NYSE:MPLN) Issues Earnings Results

MultiPlan (NYSE:MPLN) posted its earnings results on Tuesday. The company reported ($5.14) EPS for the quarter, beating analysts’ consensus estimates of ($13.50) by $8.36, Zacks reports. MultiPlan had a negative return on equity of 12.14% and a negative net margin of 163.30%. MultiPlan updated its FY 2025 guidance to EPS.

MultiPlan Stock Performance

NYSE MPLN opened at $14.15 on Tuesday. The company has a market cap of $228.82 million, a P/E ratio of -0.15 and a beta of 0.13. The firm’s 50 day moving average is $17.39. MultiPlan has a fifty-two week low of $4.80 and a fifty-two week high of $48.80. The company has a current ratio of 1.05, a quick ratio of 1.05 and a debt-to-equity ratio of 21.73.

Analyst Upgrades and Downgrades

Separately, Citigroup increased their price objective on shares of MultiPlan from $10.00 to $12.50 and gave the company a “neutral” rating in a research report on Friday, January 10th.

About MultiPlan

MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services.